Patient-reported outcomes from a randomized, active-controlled, open-label, phase 3 trial of burosumab versus conventional therapy in children with X-linked hypophosphatemia

Raja Padidela, Michael P Whyte, Francis H Glorieux, Craig F Munns, Leanne M Ward, Ola Nilsson, Anthony Portale, Jill Simmons, Noriyuki Namba, Hae Il Cheong, Pisit Pitukcheewanont, Etienne Sochett, Wolfgang Högler, Koji Muroya, Hiroyuki Tanaka, Gary Gottesman, Andrew Biggin, Farzana Perwad, Angela Williams, Annabel NixonWei Sun, Angel Chen, Alison Skrinar, Erik Imel

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)
198 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Patient-reported outcomes from a randomized, active-controlled, open-label, phase 3 trial of burosumab versus conventional therapy in children with X-linked hypophosphatemia'. Together they form a unique fingerprint.

Medicine & Life Sciences